With the Company’s recent acquisition of Emergent Health Corp. (“EMGE”), the Company believes changing its corporate name to a name that reflects a broadened business plan to be advisable. The Company’s new subsidiary, EMGE, engages in the discovery, development and marketing of products designed to better mankind. The Company believes it is positioning itself to be a leader in the field of Regenerative Medicine defined by the National Institute of Health using nutritionally designed products. Intended products are to be marketed under third-party label exemptions. Under Nevada law, the name change may be effected by filing an amendment to the Company’s Articles of Incorporation changing the Company’s corporate name.
Yahooooo. This is a missing piece that I have been awaiting... I still don't have internet therefore, It's hard for me to use my phone for explains in full details. Form 14C release today's to increased emge preferred shares 100000 to 75000 that matches with koan preferred 75000 shares. This is necessary because the preferred shares exchanges ratio is 1 for 1. They already increased koan common shares so the koan common share exchange 1-1 should be no problem. Imho.
I will cover more details when my internet is working again.